Lilly gains FDA approval to sell Cymbalta – Indianapolis Star
WASHINGTON — Eli Lilly & Co. won approval Thursday to sell the antidepressant Cymbalta, its second-biggest drug, as a treatment for pain. The Food and Drug Administration cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back …
Continue reading here:
Lilly gains FDA approval to sell Cymbalta – Indianapolis Star
Panel recommends Cymbalta for chronic pain – United Press International
WASHINGTON, Aug. 20 (UPI) — The makers of the antidepressant drug Cymbalta have narrowly won approval from a U.S
See the original post:
Panel recommends Cymbalta for chronic pain – United Press International
FDA questions wider approval of Eli Lilly’s Cymbalta – Victorville Daily Press
WASHINGTON • Federal health scientists are questioning whether the antidepressant Cymbalta is safe and effective enough to be approved for use against chronic pain. The Food and Drug Administration on Tuesday posted …
Read the original here:
FDA questions wider approval of Eli Lilly’s Cymbalta – Victorville Daily Press